MISMATCH REPAIR SYSTEM (MMR) STATUS DID NOT AFFECT SURVIVAL IN PATIENTS WITH RESECTED STAGE II COLON CANCER

被引：0
|
作者：
Hong, Y. S. [1 ]
Kim, J. E. [1 ]
Kim, K. [1 ]
Lee, J. -L. [1 ]
Jang, S. -J. [2 ]
Yu, C. S. [3 ]
Kim, J. C. [3 ]
Kim, T. W. [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Colorectal Surg, Seoul, South Korea
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [1] Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients
    Gkekas, I.
    Novotny, J.
    Fabian, P.
    Nemecek, R.
    Palmqvist, R.
    Strigard, K.
    John, S.
    Pecen, L.
    Reginacova, K.
    Gunnarsson, U.
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (02) : 392 - 401
  • [2] Clinical Experience with Mismatch Repair (MMR) Status and Onco Type DX® Colon Cancer Recurrence Score® Assay in 917 Patients with Stage II Colon Cancer
    Bailey, H.
    Anderson, J.
    Tan, V.
    Tsiatis, A. C.
    Baehner, F. L.
    Liu, J.
    Lopatin, M.
    Lee, M.
    Millward, C.
    LABORATORY INVESTIGATION, 2013, 93 : 144A - 144A
  • [3] Clinical Experience with Mismatch Repair (MMR) Status and Onco Type DX® Colon Cancer Recurrence Score® Assay in 917 Patients with Stage II Colon Cancer
    Bailey, H.
    Anderson, J.
    Tan, V.
    Tsiatis, A. C.
    Baehner, F. L.
    Liu, J.
    Lopatin, M.
    Lee, M.
    Millward, C.
    MODERN PATHOLOGY, 2013, 26 : 144A - 144A
  • [4] Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer
    Au, L.
    Grant, M.
    Haydon, A.
    Oliva, K.
    Wilkins, S.
    Segelov, E.
    Antill, Y.
    Peter, C.
    Ranchod, P.
    Polglase, A.
    Chin, M.
    Chip, F.
    Skinner, S.
    Roger, W.
    McMurrick, P.
    Shapiro, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Should mismatch repair status be determined in all stage II and III colon cancer patients?
    Taieb, Julien
    Zaanan, Aziz
    COLORECTAL CANCER, 2014, 3 (04) : 321 - 329
  • [6] MISMATCH PROTEIN REPAIR (MMR) STATUS AND ENDOMETRIAL CANCER AETIOLOGY AND SURVIVAL
    Webb, P.
    Tan, Y.
    Nagle, C. M.
    Buchanan, D.
    Spurdle, A. B.
    Obermair, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1604 - 1604
  • [7] Clinical Implications of Mismatch Repair Status in Patients With High-risk Stage II Colon Cancer
    Baek, Dong Won
    Kang, Byung Woog
    Lee, Soo Jung
    Kim, Hye Jin
    Park, Su Yeon
    Park, Jun Seok
    Choi, Gyu Seog
    Baek, Jin Ho
    Kim, Jong Gwang
    IN VIVO, 2019, 33 (02): : 649 - 657
  • [8] Mismatch Repair System (MMR) status correlates with response and survival in Non Small Cell Lung Cancer (NSCLC) patients
    Scartozzi, M.
    Franciosi, V.
    Campanini, N.
    Benedetti, G.
    Barbieri, F.
    Rossi, G.
    Berardi, R.
    Camisa, R.
    Silva, R. R.
    Santinelli, A.
    Ardizzoni, A.
    Crino, L.
    Rindi, G.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2005, 16 : 164 - 164
  • [9] Deficient mismatch repair as a prognostic marker in stage II colon cancer patients
    Gkekas, Ioannis
    Novotny, Jan
    Fabian, Pavel
    Nemecek, Radim
    Palmqvist, Richard
    Strigard, Karin
    Pecen, Ladislav
    Svoboda, Tomas
    Gurlich, Robert
    Gunnarsson, Ulf
    EJSO, 2019, 45 (10): : 1854 - 1861
  • [10] Impact of Lymph Node Status on Survival in Patients with Resected Stage IV Colon Cancer
    Bagaria, S. P.
    Ray, P.
    Beart, R. W.
    Etzioni, D. A.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S100 - S100
12345